Federico Ribet

Federico Ribet is a Researcher at KTH Royal Institute of Technology's Department of Micro and Nanosystems. He holds an M.Sc. in Nanotechnologies for ICTs from EPFL (Switzerland), INPG (France), and Politecnico di Torino (Italy). Currently a post-doctoral researcher, his work focuses on biomedical microsystems, specifically developing minimally invasive biosensors and microneedle-based technologies for continuous glucose monitoring and interstitial fluid sampling. Ribet is an inventor on multiple patents and co-founder of medtech startups Samplimy Medical AB and Sensible Healthcare Systems BV.

His research spans microfabrication of bio-compatible materials, electrowetting-on-dielectric (EWOD) actuation, and magnetic microchip assembly. Key projects include the Gluco-Touch system for painless CGM and microneedle drug delivery patches. Ribet's work emphasizes improving diabetes management through non-invasive monitoring and enhancing point-of-care diagnostics via wearable biosensors.

Ribet's lab collaborations include Prof. Niclas Roxhed and Prof. Göran Stemme. His innovations bridge clinical needs with engineering solutions, addressing challenges in sensor miniaturization, biocompatibility, and real-time diagnostic accuracy.